New Rheumatoid Arthritis Drug Sarilumab Eases Symptoms, Slows Joint Destruction In Late Trial Phase
(Photo Courtesy of Shutterstock ) The new arthritis drug Sarilumab may slash symptoms independently as well as in combination with current frontline drugs. A new type of treatment could slash symptoms for individuals suffering from rheumatoid arthritis. Following a recent year-long trial, researchers have determined that the drug sarilumab may reduce pain and joint complications by up to 66 percent. The treatment was also shown to slow joint damage by 90 percentmore than the current standard drug therapy, methotrexate. Medical researchers and developers confirmed last week that sarilumab will likely be of tremendous help for the 1.5 million U.S. adults currently living with the condition. "The initial results from this trial look quite promising in terms of reducing painful symptoms," a spokesman for Arthritis Research UK told The Daily Mail . "Although sarilumab is stil